Carcinogens

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level 

     Cancer site
 Group 1: Carcinogenic to humans
   Compounds
     C06800  Aflatoxin B1
     C10998  4-Aminobiphenyl
     C08469  Aristolochic acid
     C06269  Arsenic
     C16442  Asbestos
     C06837  Azathioprine
     C01407  Benzene
     C16444  Benzidine
     C07535  Benzo[a]pyrene
     C16460  Beryllium
     C19158  Bis(chloromethyl) ether
     C06862  Busulfan
     C16450  1,3-Butadiene
     C01413  Cadmium
     C06900  Chlorambucil
     C16446  Chlornaphazine
     C19160  Chloromethyl methyl ether
     C19161  Chromium (VI)
     C16451  Coal-tar pitch
     C07888  Cyclophosphamide
     C06933  Cyclophosphamide hydrate
     C05086  Cyclosporin A
     C07620  Diethylstilbestrol
     C19163  Erionite
     C00469  Ethanol
     C06548  Ethylene oxide
     C01576  Etoposide (in combination with cisplatin and bleomycin)
     C00067  Formaldehyde
     C07122  Melphalan
     C01864  Methoxsalen (plus ultraviolet A radiation)
     C10999  4,4'-Methylene-bis-(2-chloroaniline)
     C02227  2-Naphthylamine
     C16452  N'-Nitrosonornicotine
     C16453  4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone
     C14573  3,3',4,4',5-Pentachlorobiphenyl
     C18106  2,3,4,7,8-Pentachlorodibenzofuran
     C07591  Phenacetin
     C19162  Phosphorus-32
     C19159  Plutonium
     C16455  Radium-224
     C16456  Radium-226
     C16457  Radium-228
     C16454  Radon-222
     C07640  Semustine
     C16458  Shale oils
     C16459  Crystalline silica
     C19164  Sulfur mustard
     C07108  Tamoxifen
     C07557  2,3,7,8-Tetrachlorodibenzodioxin
     C07641  Thiotepa
     C19157  Thorium-232
     C14403  o-Toluidine
     C19557  Treosulfan
     C06793  Vinyl chloride
Liver, bile duct
Urinary bladder
Renal pelvis, ureter
Lung, skin (malignant neoplasms except melanoma), urinary bladder
Larynx, lung, ovary
Skin (malignant neoplasms except melanoma), mesothelium (pleura and peritoneum), leukaemia and/or lymphoma
Leukaemia and/or lymphoma
Urinary bladder
 
Lung
Lung
Leukaemia and/or lymphoma
Leukaemia and/or lymphoma
Lung
Leukaemia and/or lymphoma
Urinary bladder
Lung
Lung
Lung, skin (malignant neoplasms except melanoma)
Urinary bladder, leukaemia and/or lymphoma
Urinary bladder, leukaemia and/or lymphoma
Skin (malignant neoplasms except melanoma), leukaemia and/or lymphoma, multiple sites (unspecified)
Breast, vagina, uterine cervix
Mesothelium (pleura and peritoneum)
 
 
Leukaemia and/or lymphoma
Nasopharynx, leukaemia and/or lymphoma
Leukaemia and/or lymphoma
Skin (malignant neoplasms except melanoma)
 
Urinary bladder
 
 
 
 
Renal pelvis, ureter
Leukaemia and/or lymphoma
Liver, bile duct, lung, bone
Bone
Nasal cavity, paranasal sinus, bone
Nasal cavity, paranasal sinus, bone
Lung
Leukaemia and/or lymphoma
Skin (malignant neoplasms except melanoma)
Lung
Lung
Endometrium
 
Leukaemia and/or lymphoma
Liver, bile duct, gallbladder, leukaemia and/or lymphoma
Urinary bladder
Leukaemia and/or lymphoma
Liver, bile duct
   Exposure circimstances / Environment
   Infection
   Mixtures / Group of agents
   Others
 
 Group 2A: Probably carcinogenic to humans
 
 Group 2B: Possibly carcinogenic to humans
 
 Group 3: Not classifiable as to its carcinogenicity to humans
 
 Group 4: Probably not carcinogenic to humans

[ BRITE | KEGG2 | KEGG ]
Last updated: July 9, 2014
According to the IARC classification

» Japanese version